Cargando…
Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations
The mammalian target of the rapamycin (mTOR) pathway, which drives cell proliferation, is frequently hyperactivated in a variety of malignancies. Therefore, the inhibition of the mTOR pathway has been considered as an appropriate approach for cancer therapy. In this study, we examined the roles of m...
Autores principales: | Yang, Zhaojuan, Zhang, Li, Ma, Aihui, Liu, Lanlan, Li, Jinjun, Gu, Jianren, Liu, Yongzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228748/ https://www.ncbi.nlm.nih.gov/pubmed/22145042 http://dx.doi.org/10.1371/journal.pone.0028405 |
Ejemplares similares
-
CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation
por: Zhang, Lin, et al.
Publicado: (2016) -
Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting
PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer
Cells
por: Lu, Ruiqi, et al.
Publicado: (2019) -
POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1
por: Wang, Boshi, et al.
Publicado: (2019) -
Elevated glucose represses lysosomal and mTOR-related genes in renal epithelial cells composed of progenitor CD133(+) cells
por: Shrestha, Swojani, et al.
Publicado: (2021) -
Inhibition of Oxidative Stress-Elicited AKT Activation Facilitates PPARγ Agonist-Mediated Inhibition of Stem Cell Character and Tumor Growth of Liver Cancer Cells
por: Liu, Lanlan, et al.
Publicado: (2013)